Asia Pacific Blood Gas and Electrolyte Analyzer Market Forecast to 2031
Asia Pacific Blood Gas and Electrolyte Analyzer Market Forecast to 2031 – Regional Analysis – by Product (Blood Gas Analyzer, Electrolyte Analyzer, Combined Analyzer, and Others) and End User (Hospitals and Clinics, Clinical and Diagnostic Laboratories, Homecare, and Others)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
New Product Launches and Approvals Boost Asia Pacific Blood Gas and Electrolyte Analyzer Market
The development of the healthcare industry has led to a rise in the demand for blood gas and electrolyte analyzers among healthcare providers across the world. This increased demand contributes to new product developments, product launches, and approvals on a global level. In addition, major market players are involved in research and development activities to ensure the innovation and development of efficient products. Following are a few of the recent product launches and developments:
In July 2023, Siemens Healthineers launched the new Atellica CI Analyser for clinical chemistry and immunoassay testing. The US Food and Drug Administration (FDA) permitted the analyzer before its debut. It is currently accessible in several international locations. In July 2022, at the 74th American Association for Clinical Chemistry Annual Scientific Meeting and Clinical Laboratory Exposition (2022 AACC), EDAN Instruments, Inc. announced the launch of the first-ever point-of-care (POC) fluorescence-based CO-OX blood gas and chemistry analysis system, i20. The system has over 45 parameters, ranging from blood gases to electrolytes to CO-oximetry. In September 2021, Sensa Core Medical Instrumentation APAC launched ST-200 CC Blood Gas Analyzers – Ultra Smart for use in clinics, hospitals, and diagnostic centers. The highly advanced blood gas model from the company is the ST-200 CC Ultra Smart ABGEM blood gas analyzer. It is a fully automated, microprocessor-controlled electrolyte system that performs arterial blood gas analysis and electrolyte measurements using current direct measurement with ION selective electrode (ISE), impedance (Hct), and amperometry (pO2) technologies. In April 2021, Siemens Healthiness EU launched the epoc Blood Analysis System, a wireless, portable device that provides patient-side results in less than a minute. It measures hematocrit and lactate on a single room temperature-stable test card, complete blood gas, and a basic metabolic panel. It is aided by its support of COVID-19 response efforts, as blood gas testing is essential for managing infected individuals. Thus, an increase in product developments, launches, and strategic collaborations among market players is likely to create ample opportunities for the blood gas and electrolyte analyzers market in the coming years.
Asia Pacific Blood Gas and Electrolyte Analyzer Market Overview
The Asia Pacific blood gas and electrolyte analyzer market is segmented into China, Japan, Australia, India, South Korea, and the Rest of Asia Pacific. The blood gas and electrolyte analyzer market in Asia Pacific is expected to grow considerably owing to the rising awareness regarding kidney and respiratory diseases in countries such as India, Australia, and South Korea. The market is also expected to grow due to the rising development of the medical device industry in countries such as Japan and China. In addition, the development in the respiratory sectors across these countries is estimated to fuel the market growth during the forecast period.
Asia Pacific Blood Gas and Electrolyte Analyzer Market Revenue and Forecast to 2031 (US$ Million)
Asia Pacific Blood Gas and Electrolyte Analyzer Market Segmentation
The Asia Pacific blood gas and electrolyte analyzer market is categorized into product, end user, and country.
Based on product, the Asia Pacific blood gas and electrolyte analyzer market is categorized into blood gas analyzer, electrolyte analyzer, combined analyzer, and others. The combined analyzer segment held the largest market share in 2023.
By end user, the Asia Pacific blood gas and electrolyte analyzer market is segmented into hospitals and clinics, clinical and diagnostic laboratories, homecare, and others. The clinical and diagnostic laboratories segment held the largest market share in 2023.
By country, the Asia Pacific blood gas and electrolyte analyzer market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific blood gas and electrolyte analyzer market share in 2023.
Abbott Laboratories, Dalko Diagnostics Private Limited, Erba Diagnostics Mannheim GmbH, Hoffmann-La Roche Ltd, Medica Corporation, Nova Biomedical Corporation, Siemens Healthineers AG, Werfen SA, Radiometer Medical ApS, and Sensa Core Medical Instrumentation Pvt Ltd. are some of the leading companies operating in the Asia Pacific blood gas and electrolyte analyzer market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to Business Market Insights’ research, the Asia Pacific blood gas and electrolyte analyzer market was valued at US$ 303.33 million in 2023 and is expected to reach US$ 531.84 million by 2031, registering a CAGR of 7.3% from 2023 to 2031. Rising adoption of point-of-care diagnostics and new product launches and approvals are among the critical factors attributed to drive the Asia Pacific blood gas and electrolyte analyzer market growth.
Point-of-care testing offers immediate diagnostic results at or near the patient’s location, enabling rapid clinical decision-making, streamlined workflows, and enhanced patient outcomes. The need for timely interventions, efficient diagnostic processes, and personalized healthcare delivery fuels the demand for decentralized testing solutions. Blood gas and electrolyte analyzers allow healthcare providers to perform critical diagnostic tests at the patient’s bedside, in the emergency department or in remote settings, facilitating on-the-spot assessment of blood gas parameters, electrolyte levels, and acid-base status. The accessibility and immediacy of point-of-care analyzers empower clinicians to initiate appropriate treatments promptly, monitor patient responses in real time, and optimize clinical decision-making in acute care scenarios.
The shift toward point-of-care diagnostics drives technological advancements in blood gas and electrolyte analyzers, focusing on compact, automated, and easy-to-use devices that deliver accurate and fast results. The analyzers leverage advanced technologies to provide precise measurements, quality assurance features, and connectivity options for data management and integration with electronic health records. The seamless integration of point-of-care analyzers into healthcare workflows enhances operational efficiency, reduces turnaround times for results, and improves the overall quality of patient care. The integration revolutionizes the diagnostic process, empowering healthcare providers with immediate data insights and enabling timely interventions that enhance patient management and clinical decision-making. Thus, as healthcare settings embrace the advantages of point-of-care testing, the demand for portable and user-friendly blood gas and electrolyte analyzers is rising.
On the contrary, high costs of analysers hamper the growth of Asia Pacific blood gas and electrolyte analyzer market.
Based on product, the Asia Pacific blood gas and electrolyte analyzer market is categorized into blood gas analyzer, electrolyte analyzer, combined analyzer, and others. The combined analyzer segment held 63.7% market share in 2023, amassing US$ 193.29 million. It is projected to garner US$ 347.95 million by 2031 to register 7.6% CAGR during 2023–2031.
By end user, the Asia Pacific blood gas and electrolyte analyzer market is categorized into hospitals and clinics, clinical and diagnostic laboratories, homecare, and others. The clinical and diagnostic laboratories segment held 68.3% share of Asia Pacific blood gas and electrolyte analyzer market in 2023, amassing US$ 207.16 million. It is projected to garner US$ 371.42 million by 2031 to expand at 7.6% CAGR from 2023 to 2031.
Based on country, the Asia Pacific blood gas and electrolyte analyzer market is categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Our regional analysis states that China captured 28.7% share of Asia Pacific blood gas and electrolyte analyzer market in 2023. It was assessed at US$ 87.15 million in 2023 and is likely to hit US$ 142.59 million by 2031, registering a CAGR of 6.3% during 2023–2031.
Key players operating in the Asia Pacific blood gas and electrolyte analyzer market are Abbott Laboratories, Dalko Diagnostics Private Limited, Erba Diagnostics Mannheim GmbH, Hoffmann-La Roche Ltd, Medica Corporation, Nova Biomedical Corporation, Siemens Healthineers AG, Werfen SA, Radiometer Medical ApS, and Sensa Core Medical Instrumentation Pvt Ltd., among others.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the Europe blood gas and electrolyte analyzer market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe blood gas and electrolyte analyzer market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
1. Introduction
1.1 The Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Blood Gas and Electrolyte Analyzer Market – Key Market Dynamics
4.1 Market Drivers
4.1.1 Increasing Number of Patients in Emergency Units of Hospitals
4.1.2 Rising Adoption of Point-of-Care Diagnostics
4.2 Market Restraints
4.2.1 High Costs of Analysers
4.3 Market Opportunities
4.3.1 New Product Launches and Approvals
4.4 Future Trends
4.4.1 Automation and Artificial Intelligence in Blood Gas and Electrolyte Analyzer
4.5 Impact of Drivers and Restraints:
5. Blood Gas and Electrolyte Analyzer Market – Asia Pacific Market Analysis
5.1 Blood Gas and Electrolyte Analyzer Market Revenue (US$ Million), 2021-2031
5.2 Blood Gas and Electrolyte Analyzer Market Forecast Analysis
6. Asia Pacific Blood Gas and Electrolyte Analyzer Market Analysis – by Product
6.1 Blood Gas Analyzer
6.1.1 Overview
6.1.2 Blood Gas Analyzer: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
6.2 Electrolyte Analyzer
6.2.1 Overview
6.2.2 Electrolyte Analyzer: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
6.3 Combined Analyzer
6.3.1 Overview
6.3.2 Combined Analyzer: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
7. Asia Pacific Blood Gas and Electrolyte Analyzer Market Analysis – by End User
7.1 Hospitals and Clinics
7.1.1 Overview
7.1.2 Hospitals and Clinics: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Clinical and Diagnostic Laboratories
7.2.1 Overview
7.2.2 Clinical and Diagnostic Laboratories: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Homecare
7.3.1 Overview
7.3.2 Homecare: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
8. Asia Pacific Blood Gas and Electrolyte Analyzer Market – Country Analysis
8.1 Asia Pacific
8.1.1 Asia Pacific: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast Analysis – by Country
8.1.1.1 Asia Pacific: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast Analysis – by Country
8.1.1.2 China: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
8.1.1.2.1 China: Blood Gas and Electrolyte Analyzer Market Breakdown, by Product
8.1.1.2.2 China: Blood Gas and Electrolyte Analyzer Market Breakdown, by End User
8.1.1.3 Japan: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
8.1.1.3.1 Japan: Blood Gas and Electrolyte Analyzer Market Breakdown, by Product
8.1.1.3.2 Japan: Blood Gas and Electrolyte Analyzer Market Breakdown, by End User
8.1.1.4 India: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
8.1.1.4.1 India: Blood Gas and Electrolyte Analyzer Market Breakdown, by Product
8.1.1.4.2 India: Blood Gas and Electrolyte Analyzer Market Breakdown, by End User
8.1.1.5 Australia: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
8.1.1.5.1 Australia: Blood Gas and Electrolyte Analyzer Market Breakdown, by Product
8.1.1.5.2 Australia: Blood Gas and Electrolyte Analyzer Market Breakdown, by End User
8.1.1.6 South Korea: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
8.1.1.6.1 South Korea: Blood Gas and Electrolyte Analyzer Market Breakdown, by Product
8.1.1.6.2 South Korea: Blood Gas and Electrolyte Analyzer Market Breakdown, by End User
8.1.1.7 Rest of APAC: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
8.1.1.7.1 Rest of APAC: Blood Gas and Electrolyte Analyzer Market Breakdown, by Product
8.1.1.7.2 Rest of APAC: Blood Gas and Electrolyte Analyzer Market Breakdown, by End User
9. Industry Landscape
9.1 Overview
9.2 Organic Growth Strategies
9.2.1 Overview
9.3 Brand Share/Revenue- 2022
10. Company Profiles
10.1 Abbott Laboratories
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Dalko Diagnostics Private Limited
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Erba Diagnostics Mannheim GmbH
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Hoffmann-La Roche Ltd
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Medica Corporation
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Nova Biomedical Corporation
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Siemens Healthineers AG
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Werfen SA
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Radiometer Medical ApS
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 Sensa Core Medical Instrumentation Pvt Ltd
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Products and Services
10.10.4 Financial Overview
10.10.5 SWOT Analysis
10.10.6 Key Developments
11. Appendix
11.1 About The Research Team
11.2 Glossary of Terms
Table 1. Asia Pacific Blood Gas and Electrolyte Analyzer Market Segmentation
Table 2. Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
Table 3. Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million) – by Product
Table 4. Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 5. Asia Pacific: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 6. China: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 7. China: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 8. Japan: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 9. Japan: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 10. India: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 11. India: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 12. Australia: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 13. Australia: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 14. South Korea: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 15. South Korea: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 16. Rest of APAC: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 17. Rest of APAC: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 18. Recent Organic Growth Strategies in the Blood Gas and Electrolyte Analyzer Market
Table 19. Brand Share of Products for Each Company (US$ Million)
Table 20. Glossary of Terms, Blood Gas and Electrolyte Analyzer Market
Figure 1. Asia Pacific Blood Gas and Electrolyte Analyzer Market Segmentation, by country
Figure 2. Blood Gas and Electrolyte Analyzer Market – Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Blood Gas and Electrolyte Analyzer Market Revenue (US$ Million), 2021-2031
Figure 5. Blood Gas and Electrolyte Analyzer Market Share (%) – by Product (2023 and 2031)
Figure 6. Blood Gas Analyzer: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Electrolyte Analyzer: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Combined Analyzer: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
Figure 9. Others: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Blood Gas and Electrolyte Analyzer Market Share (%) – by End User (2023 and 2031)
Figure 11. Hospitals and Clinics: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Clinical and Diagnostic Laboratories: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. Homecare: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. Others: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031 (US$ Million)
Figure 15. Asia Pacific : Blood Gas and Electrolyte Analyzer Market, by Key Country – Revenue (2023) (USD Million)
Figure 16. Asia Pacific: Blood Gas and Electrolyte Analyzer Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 17. China: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031(US$ Million)
Figure 18. Japan: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031(US$ Million)
Figure 19. India: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031(US$ Million)
Figure 20. Australia: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031(US$ Million)
Figure 21. South Korea: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031(US$ Million)
Figure 22. Rest of APAC: Blood Gas and Electrolyte Analyzer Market – Revenue and Forecast to 2031(US$ Million)
The List of Companies – Asia Pacific Blood Gas and Electrolyte Analyzer Market
o Abbott Laboratories.
o Dalko Diagnostics Private Limited.
o Erba Diagnostics Mannheim GmbH.
o Hoffmann-La Roche Ltd.
o Medica Corporation.
o Nova Biomedical Corporation.
o Siemens Healthineers AG.
o Werfen SA.
o Radiometer Medical ApS.
o Sensa Core Medical Instrumentation Pvt Ltd.
You must be logged in to post a review.
Reviews
There are no reviews yet.